Latest Financial Updates

Read latest financial news update from our blog

Live: The day in politics, Monday, July 31
Live: The day in politics, Monday, July 31

Welcome to Stuff’s daily election live blog, where we cover all the key political news ahe...

Admin | Finance | 2 months ago

Top HealthTech Startups of 2023
Top HealthTech Startups of 2023

The healthcare industry is experiencing a profound transformation with the rise of healtht...

Admin | Finance | 2 months ago

Fog restrictions lifted at Auckland Airport after 10 domestic flights cancelled
Fog restrictions lifted at Auckland Airport after 10 domestic flights cancelled

Domestic jet flights to the main centres and Queenstown have not been affected. (File phot...

Admin | Finance | 2 months ago

Lush bosses pocket £5m in bonuses after claiming £5m in government support
Lush bosses pocket £5m in bonuses after claiming £5m in government support

Lush managers received £5m in bonuses last year after the retailer claimed £5.1m in state...

Admin | Finance | 2 months ago

Arkansas law that would allow librarians to be criminally charged blocked by federal judge
Arkansas law that would allow librarians to be criminally charged blocked by federal judge

A banned books display is seen at Vroman's Bookstore in Pasadena, Calif., in September 202...

Admin | Finance | 2 months ago

Sam Bankman-Fried Needs Jail Time After Tampering With Witnesses and Impeding Investigations: DOJ
Sam Bankman-Fried Needs Jail Time After Tampering With Witnesses and Impeding Investigations: DOJ

The Department of Justice (DOJ) says it is unsatisfied with FTX founder Sam Bankman-Fried’...

Admin | Finance | 2 months ago

Oracle Is A HOLD, But Should Remain On Your Wathclist (NYSE:ORCL)
Oracle Is A HOLD, But Should Remain On Your Wathclist (NYSE:ORCL)

Justin Sullivan Introduction As a dividend growth investor, I seek new investment opport...

Admin | Finance | 2 months ago

UroGen to raise $120m after positive bladder cancer trial results
UroGen to raise $120m after positive bladder cancer trial results

UroGen Pharma (TASE: URGN), which develops uro-oncological treatments, last week published...

Admin | Finance | 2 months ago

Join Our Newsletter

join our newsletter to receive update from us